Brief: Ac Immune Says Informed Enrollment Has Been Temporarily Paused For Phase 2B Retain Trial
17/02/2026 21:49
Feb 17 (Reuters) - AC Immune SA ACIU.O: AC IMMUNE SA: INFORMED BY JANSSEN PHARMACEUTICALS THAT ENROLLMENT HAS BEEN TEMPORARILY PAUSED FOR PHASE 2B RETAIN TRIAL AC IMMUNE SA: TEMPORARY PAUSE IN PHASE 2B RETAIN TRIAL RECRUITMENT IS VOLUNTARY & NOT RELATED TO NEW SAFETY FINDINGS Source text: [ID:n0000950103-26-002195] Further company coverage: ACIU.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on AC Immune AG
See all newsAC Immune rises after Parkinson's drug shows promise in mid-stage trial
Brief: Ac Immune Reports Positive Safety & Immunogenicity At Week-100 In Part 1 Of Vacsyn Phase 2 Trial Of Aci-7104
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
U.S. STOCKS ON THE MOVE-Duke Energy, Sea, Cardinal Health